This week, the overall grades of eight Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
The End of the Road for Tesla’s Run?
Goldman's swift kick took the wind out of Tesla Motors' 2013 run and finally pleased the shorts ... but it didn't necessarily knock TSLA out cold. More
5 Stocks With Strong Earnings Momentum — KNSY MIL ALJ AMED URS
This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader. More
3 Stocks Just Begging for Analyst Upgrades
Wall Street analysts hate to be late to the game, but often are ... still, their upgrades can provide some oomph. Monitor these stocks for some analyst aid. More
5 Expensive Stocks That Are Flying High But Worth the Premium
If you're an investor who's overly concerned with share price, control your urge to run away from these big-sticker winners. More
